Published on in Vol 7, No 4 (2018): April

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/9024, first published .
Comparing the Effects of Combined Oral Contraceptives Containing Progestins With Low Androgenic and Antiandrogenic Activities on the Hypothalamic-Pituitary-Gonadal Axis in Patients With Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis

Comparing the Effects of Combined Oral Contraceptives Containing Progestins With Low Androgenic and Antiandrogenic Activities on the Hypothalamic-Pituitary-Gonadal Axis in Patients With Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis

Comparing the Effects of Combined Oral Contraceptives Containing Progestins With Low Androgenic and Antiandrogenic Activities on the Hypothalamic-Pituitary-Gonadal Axis in Patients With Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis

Journals

  1. Skiba M, Islam R, Bell R, Davis S. Hormonal contraceptive use in Australian women: Who is using what?. Australian and New Zealand Journal of Obstetrics and Gynaecology 2019;59(5):717 View
  2. Ovsyannikova T, Kulikov I. Hormonal contraception in women of reproductive age: endocrinological aspects. Gynecology 2019;21(1):65 View
  3. Landersoe S, Larsen E, Forman J, Birch Petersen K, Kroman M, Frederiksen H, Juul A, Nøhr B, Løssl K, Nielsen H, Nyboe Andersen A. Ovarian reserve markers and endocrine profile during oral contraception: Is there a link between the degree of ovarian suppression and AMH?. Gynecological Endocrinology 2020;36(12):1090 View
  4. Amiri M, Nahidi F, Yarandi R, Khalili D, Tohidi M, Tehrani F. Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial. Health and Quality of Life Outcomes 2020;18(1) View
  5. Morgante G, Cappelli V, Troìa L, De Leo V. Evaluation of different antiandrogenic progestins on clinical and biochemical variables in polycystic ovary syndrome. The European Journal of Contraception & Reproductive Health Care 2020;25(3):176 View
  6. Aversa A, La Vignera S, Rago R, Gambineri A, Nappi R, Calogero A, Ferlin A. Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions. Frontiers in Endocrinology 2020;11 View
  7. Qu X, Donnelly R. Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome. International Journal of Molecular Sciences 2020;21(21):8191 View
  8. Waiyaput W, Wattanakamolchai K, Tingthanatikul Y, Lertvikool S, Tantanavipas S, Dittharot K, Sroyraya M, Sophonsritsuk A. Effect of combined contraceptive pill on immune cell of ovarian endometriotic tissue. Journal of Ovarian Research 2021;14(1) View